Kolexia
Tabouret Emeline
Oncologie médicale
Hôpital La Timone
Marseille, France
193 Activités
482 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glioblastome Gliome Tumeurs du cerveau Lymphomes Récidive tumorale locale Méningiome Métastase tumorale Oligodendrogliome Astrocytome

Industries

Leo Pharma
4 collaboration(s)
Dernière en 2022
NOVOCURE FRANCE SAS
2 collaboration(s)
Dernière en 2022
AstraZeneca
2 collaboration(s)
Dernière en 2021
Servier
1 collaboration(s)
Dernière en 2023

Dernières activités

3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Neuro-oncology   07 mars 2024
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
Journal of neuro-oncology   07 mars 2024
MM-Predict: Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   04 mars 2024
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
MUCIGLIO-01: Predictive Value of Soluble CD146 in Patients With Recurrent Glioblastoma Treated by Bevacizumab
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   01 février 2024
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Journal of the neurological sciences   18 décembre 2023
Primary central nervous system lymphoma with initial spinal cord involvement (PCNSL-SC) is a rare entity: 4 case reports and review of literature
Revue neurologique   26 octobre 2023
546P Early urinary potassium level is predictive of delayed methotrexate (MTX) elimination in patients with primary central nervous system lymphoma (PCNSL)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
HITCH: Establishment of Pre-clinical Stem Line and Tumoroid Models of Brain Tumors
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   13 septembre 2023
P02.09.A THE PLASTICITY AND SURVIVAL OF GLIOBLASTOMA STEM CELLS DEPEND ON GD3, WHOSE INHIBITION IS SYNERGISTIC WITH RADIO-CHEMOTHERAPY
Abstracts from the 18th Meeting of the European Association of Neuro-Oncology   08 septembre 2023